$IDAI
T Stamp Inc

2022 Q3 Form 10-Q Financial Statement

#000141057822002705 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $1.348M $708.3K $2.096M
YoY Change 308.5% -1.55% 69.04%
Cost Of Revenue $529.0K $348.2K $297.7K
YoY Change 112.15% 0.46% -71.65%
Gross Profit $819.5K $360.1K $1.798M
YoY Change 914.94% -3.41% 899.12%
Gross Profit Margin 60.77% 50.84% 85.8%
Selling, General & Admin $3.282M $2.533M $2.212M
YoY Change 43.17% 29.69% -26.28%
% of Gross Profit 400.47% 703.33% 122.98%
Research & Development $777.8K $574.5K $1.403M
YoY Change 34.39% 81.47% -28.07%
% of Gross Profit 94.92% 159.53% 77.99%
Depreciation & Amortization $42.00K $42.00K $151.0K
YoY Change 320.0% 133.33% 25.86%
% of Gross Profit 5.13% 11.66% 8.4%
Operating Expenses $4.792M $3.646M $3.765M
YoY Change 46.56% 31.71% -25.73%
Operating Profit -$3.443M -$2.938M -$1.967M
YoY Change 17.14% 43.38% -59.78%
Interest Expense $8.420K $34.12K -$28.69K
YoY Change -114.47% -535.76% -4.37%
% of Operating Profit
Other Income/Expense, Net $3.220K $15.63K -$28.25K
YoY Change -103.32% -80.96% -112.84%
Pretax Income -$3.440M -$2.922M -$2.024M
YoY Change 13.29% 48.57% -64.18%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.440M -$2.922M -$2.023M
YoY Change 13.31% 48.64% -64.19%
Net Earnings / Revenue -255.09% -412.58% -96.53%
Basic Earnings Per Share -$0.15 -$0.13
Diluted Earnings Per Share -$0.15 -$0.13 -$86.91K
COMMON SHARES
Basic Shares Outstanding 23.57M 23.27M
Diluted Shares Outstanding 23.47M 23.27M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.931M $2.828M $3.476M
YoY Change 1585.41% 130.6% 136.44%
Cash & Equivalents $2.931M $2.828M $3.476M
Short-Term Investments
Other Short-Term Assets $342.0K $549.1K $927.8K
YoY Change -29.05% -5.96% 101.7%
Inventory
Prepaid Expenses $227.2K $302.0K $320.0K
Receivables $1.325M $738.5K $1.278M
Other Receivables $169.2K $187.5K $82.44K
Total Short-Term Assets $4.767M $4.303M $5.764M
YoY Change 411.26% 92.7% 176.55%
LONG-TERM ASSETS
Property, Plant & Equipment $330.2K $368.6K $111.8K
YoY Change 165.99% -71.61% -12.66%
Goodwill $1.249M $1.249M $1.249M
YoY Change 0.0% 0.0%
Intangibles $210.4K $232.1K $201.8K
YoY Change 2.98% 801.65%
Long-Term Investments
YoY Change
Other Assets $150.6K $150.6K $178.1K
YoY Change -50.34% -33.99% -10.01%
Total Long-Term Assets $3.315M $3.315M $2.900M
YoY Change 8.95% 11.66% 6.3%
TOTAL ASSETS
Total Short-Term Assets $4.767M $4.303M $5.764M
Total Long-Term Assets $3.315M $3.315M $2.900M
Total Assets $8.082M $7.618M $8.665M
YoY Change 103.31% 46.44% 80.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $280.8K $397.9K $304.1K
YoY Change -5.66% 148.56% -20.07%
Accrued Expenses $941.9K $468.8K $1.060M
YoY Change 21.56% -28.93% 30.94%
Deferred Revenue $1.615M $215.7K $503.4K
YoY Change 767.01% 7.32%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $118.9K $118.9K $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.115M $1.365M $2.400M
YoY Change 70.39% -1.65% -2.1%
LONG-TERM LIABILITIES
Long-Term Debt $804.6K $857.9K $856.3K
YoY Change -7.17% 56.54%
Other Long-Term Liabilities $404.8K $445.9K $374.7K
YoY Change 18.32% 54.95% 29.2%
Total Long-Term Liabilities $804.6K $857.9K $856.3K
YoY Change -7.17% 2.65% 195.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.115M $1.365M $2.400M
Total Long-Term Liabilities $804.6K $857.9K $856.3K
Total Liabilities $4.325M $2.668M $3.631M
YoY Change 42.39% 11.85% 32.56%
SHAREHOLDERS EQUITY
Retained Earnings -$35.26M -$31.82M -$27.21M
YoY Change 40.03% 49.9%
Common Stock $242.6K $232.9K $204.8K
YoY Change 26.77% 15.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $282.6K
Shareholders Equity $3.596M $4.788M $4.872M
YoY Change
Total Liabilities & Shareholders Equity $8.082M $7.618M $8.665M
YoY Change 103.31% 46.44% 80.03%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$3.440M -$2.922M -$2.023M
YoY Change 13.31% 48.64% -64.19%
Depreciation, Depletion And Amortization $42.00K $42.00K $151.0K
YoY Change 320.0% 133.33% 25.86%
Cash From Operating Activities -$982.3K -$2.718M -$1.444M
YoY Change -23.8% -31.74% 42.97%
INVESTING ACTIVITIES
Capital Expenditures -$210.8K -$292.9K -$136.4K
YoY Change 42.83% -25.62% -164.96%
Acquisitions
YoY Change
Other Investing Activities $0.00 $13.36K $0.00
YoY Change -114.74%
Cash From Investing Activities -$210.8K -$279.5K -$136.4K
YoY Change 42.81% -42.29% -35.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.393M -9.640K 4.820M
YoY Change 295.19% -100.23% 9540.4%
NET CHANGE
Cash From Operating Activities -982.3K -2.718M -1.444M
Cash From Investing Activities -210.8K -279.5K -136.4K
Cash From Financing Activities 1.393M -9.640K 4.820M
Net Change In Cash 199.4K -3.007M 3.240M
YoY Change -118.39% 942.21% -376.91%
FREE CASH FLOW
Cash From Operating Activities -$982.3K -$2.718M -$1.444M
Capital Expenditures -$210.8K -$292.9K -$136.4K
Free Cash Flow -$771.5K -$2.425M -$1.308M
YoY Change -32.41% -32.42% 7.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
5
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
dei Amendment Flag
AmendmentFlag
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41252
dei Entity Registrant Name
EntityRegistrantName
T Stamp Inc
dei Entity Address Address Line1
EntityAddressAddressLine1
3017 Bolling Way NE, Floors 1 and 2
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23266587
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18828225
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23008941
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18435847
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23266587
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18828225
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23008941
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18435847
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Central Index Key
EntityCentralIndexKey
0001718939
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20475143
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23285733
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30305
dei Local Phone Number
LocalPhoneNumber
N/A
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
IDAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23568298
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2827563
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3475695
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
738516
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1278286
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
34181
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
13648
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
702404
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
CY2022Q2 us-gaap Assets Current
AssetsCurrent
4302664
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5764231
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1309394
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022Q2 us-gaap Goodwill
Goodwill
1248664
CY2021Q4 us-gaap Goodwill
Goodwill
1248664
CY2022Q2 idai Digital Assets
DigitalAssets
6115
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
252773
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
468842
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
232051
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
201807
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368602
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150601
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022Q2 us-gaap Assets
Assets
7618091
CY2021Q4 us-gaap Assets
Assets
8664654
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
397873
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
304140
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
163157
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
215720
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
503433
CY2021Q4 idai Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
280108
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
118920
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1364512
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2399986
CY2022Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
297634
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
374694
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
19189
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12252
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
857939
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
856258
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
148222
CY2022Q2 us-gaap Liabilities
Liabilities
2668307
CY2021Q4 us-gaap Liabilities
Liabilities
3630938
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23285733
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20475143
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
232857
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
204751
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
282565
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
282565
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36240605
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31822079
CY2022Q2 us-gaap Minority Interest
MinorityInterest
161439
CY2021Q4 us-gaap Minority Interest
MinorityInterest
161439
idai Others Non Operating Income
OthersNonOperatingIncome
12614
idai Others Non Operating Income
OthersNonOperatingIncome
10806
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
272
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
94785
CY2022Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
74407
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
130267
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
211824
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
183900
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31822534
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27208186
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4949784
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7618091
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8664654
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
708288
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
719409
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3529333
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1251692
CY2022Q2 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
348166
CY2021Q2 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
346594
idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
1042144
idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
604013
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
574490
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
316579
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1022903
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
483819
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2532849
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1953047
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5698695
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3874884
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
190703
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
152171
us-gaap Depreciation And Amortization
DepreciationAndAmortization
344631
us-gaap Depreciation And Amortization
DepreciationAndAmortization
273623
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3646208
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2768391
us-gaap Operating Expenses
OperatingExpenses
8108373
us-gaap Operating Expenses
OperatingExpenses
5236339
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2937920
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2048982
us-gaap Operating Income Loss
OperatingIncomeLoss
-4579040
us-gaap Operating Income Loss
OperatingIncomeLoss
-3984647
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2354
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7829
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6312
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-40049
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-36472
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77060
CY2021Q2 idai Grant Income
GrantIncome
54557
idai Grant Income
GrantIncome
51293
CY2022Q2 idai Impairment Of Digital Assets
ImpairmentOfDigitalAssets
23885
idai Impairment Of Digital Assets
ImpairmentOfDigitalAssets
23885
CY2022Q2 idai Others Non Operating Income
OthersNonOperatingIncome
5673
CY2021Q2 idai Others Non Operating Income
OthersNonOperatingIncome
35365
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1966889
us-gaap Profit Loss
ProfitLoss
-4614348
us-gaap Profit Loss
ProfitLoss
-3998782
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-864
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-864
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
36185
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15634
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
82093
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35308
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14135
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2922286
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1966889
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4614348
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3998782
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-2922286
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2922286
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1966025
us-gaap Net Income Loss
NetIncomeLoss
-4614348
us-gaap Net Income Loss
NetIncomeLoss
-3997918
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23266587
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18828225
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23008941
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18435847
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-2922286
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1966889
us-gaap Profit Loss
ProfitLoss
-4614348
us-gaap Profit Loss
ProfitLoss
-3998782
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34726
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
106
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27924
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44728
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34726
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
106
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27924
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44728
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2957012
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1966783
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4586424
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3954054
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-864
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-864
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2957012
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1965919
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4586424
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3953190
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2692921
CY2021Q2 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
750
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1566097
CY2021Q2 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
28004
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
657928
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
106
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-864
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1966025
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2978917
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7416372
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18278
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15430
CY2022Q2 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
27930
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
459646
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34726
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2922286
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4949784
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2073659
idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
750
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3972589
idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
55934
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
830039
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44728
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-864
us-gaap Net Income Loss
NetIncomeLoss
-3997918
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2978917
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
3383762
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71592
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
203438
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
55838
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15430
idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
55860
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
747432
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27924
us-gaap Net Income Loss
NetIncomeLoss
-4614348
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4949784
us-gaap Net Income Loss
NetIncomeLoss
-4614348
us-gaap Net Income Loss
NetIncomeLoss
-3997918
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-864
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
344631
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
273623
us-gaap Share Based Compensation
ShareBasedCompensation
747432
us-gaap Share Based Compensation
ShareBasedCompensation
830039
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77060
idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
55860
idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
55934
idai Impairment Of Digital Assets
ImpairmentOfDigitalAssets
23885
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-539770
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
278629
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
20533
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-11229
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-294198
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
124899
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27539
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
30183
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-522797
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-369952
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-89616
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-174468
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-287713
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-175270
idai Increase Decrease In Customer Deposits Liability
IncreaseDecreaseInCustomerDepositsLiability
-280108
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3858860
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3981358
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18117
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31256
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
395748
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
254919
idai Payments For Proceed From Productive Assets
PaymentsForProceedFromProductiveAssets
-13362
idai Payments For Proceed From Productive Assets
PaymentsForProceedFromProductiveAssets
90621
idai Payments To Acquire Digital Assets
PaymentsToAcquireDigitalAssets
30000
idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
93749
idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
107521
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524252
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-484317
idai Proceeds From Exercise Of Warrants To Common Stock
ProceedsFromExerciseOfWarrantsToCommonStock
3385935
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71592
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203439
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3973339
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
55838
idai Principal Payment On Derivatives
PrincipalPaymentOnDerivatives
30098
us-gaap Repayments Of Debt
RepaymentsOfDebt
344219
idai Proceeds From Loan From Maltese Government
ProceedsFromLoanFromMalteseGovernment
548070
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3686706
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4177190
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48274
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44727
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-648132
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-243758
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3475695
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469952
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2827563
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1226194
us-gaap Interest Paid Net
InterestPaidNet
8
us-gaap Interest Paid Net
InterestPaidNet
29053
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
297240
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
61582
us-gaap Net Income Loss
NetIncomeLoss
-4610000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3860000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31820000
idai Cessation Period For Implementing Ice Obligations
CessationPeriodForImplementingIceObligations
P90D
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">—</span><i style="font-style:italic;"> </i>The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates that include, but are not limited to, percentage of completion related to revenue contracts that are not fully complete at the end of a fiscal quarter, capitalization and estimated useful life of internal-use software, the allowance for doubtful accounts, the fair value of financial assets and liabilities, the useful lives of property and equipment and intangible assets, the recoverability of goodwill, stock-based compensation including the determination of the fair value of our common stock, impairment of long-lived assets, the valuation of deferred tax assets and uncertain tax positions, and warrant liabilities. We base our estimates on assumptions, both historical and forward-looking trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Major Customers and Concentration of Risks </span><span style="font-style:italic;font-weight:bold;">—</span> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. We maintain our cash and cash equivalents with high-quality financial institutions mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of June 30, 2022, and December 31, 2021, the Company had $801 thousand and $2.25 million in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">Three customers represented 96% and 92% of the balance of total accounts receivable as of June 30, 2022 and December 31, 2021, respectively. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of June 30, 2022 and December 31, 2021, the Company had not experienced any significant losses on its accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the three and six months ended June 30, 2022, the Company sold to primarily four customers which made up approximately 94% and 98%, respectively, of total net revenue. The remaining revenue recognized during the three and six months ended June 30, 2022, which made up approximately 6% and 2%, respectively, of total net revenue, was from various other customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the three and six months ended June 30, 2021, three customers made up approximately 98% and 97%, respectively, of total net revenue. The remaining revenue recognized during the three and six months ended June 30, 2021, which made up approximately 2% and 3%, respectively, of total net revenue, was from various other customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">The loss of, or substantial reduction, in statements of work from the Company’s major customers, could have a material effect on the consolidated financial statements.</p>
idai Number Of Customers
NumberOfCustomers
3
CY2021 idai Number Of Customers
NumberOfCustomers
3
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
24000
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
65000
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
124000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
60000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1309394
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
127000
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5376663
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7752009
CY2021Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
67000
CY2020Q1 idai Warrants Strike Price
WarrantsStrikePrice
1.6000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42241
CY2021Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
112000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
246000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
218000
CY2022Q2 idai Maximum Number Of Warrants Issued To Purchase Common Stock In Future
MaximumNumberOfWarrantsIssuedToPurchaseCommonStockInFuture
1000000.00
idai Percentage Of Discount Of Future Issuance Of Preferred Stock
PercentageOfDiscountOfFutureIssuanceOfPreferredStock
0.20
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
50000
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
32092
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
125000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
301988
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
319996
CY2022Q2 us-gaap Prepaid Rent
PrepaidRent
88755
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
100425
CY2022Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
62789
CY2021Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
68798
CY2022Q2 idai Prepaid Sponsorship Current
PrepaidSponsorshipCurrent
50000
CY2021Q4 idai Prepaid Sponsorship Current
PrepaidSponsorshipCurrent
100000
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
90501
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
75106
CY2022Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
108371
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
332277
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
702404
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
idai Capitalized Computer Software Useful Life
CapitalizedComputerSoftwareUsefulLife
P5Y
CY2022Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2934143
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2538395
CY2022Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1624749
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1378351
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
458235
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154009
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89633
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368602
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022Q2 us-gaap Depreciation
Depreciation
42000
CY2021Q2 us-gaap Depreciation
Depreciation
18000
us-gaap Depreciation
Depreciation
52000
us-gaap Depreciation
Depreciation
29000
CY2022Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
150601
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
178140
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150601
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022Q2 idai Compensation Payable
CompensationPayable
96120
CY2021Q4 idai Compensation Payable
CompensationPayable
597849
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
25826
CY2022Q2 idai Accrued Employee Taxes
AccruedEmployeeTaxes
284906
CY2021Q4 idai Accrued Employee Taxes
AccruedEmployeeTaxes
349256
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
61990
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
112427
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
468842
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
24000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
368191
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
294629
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
136141
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
92822
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
232051
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201807
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
57329
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
112950
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
53929
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7843
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
232051
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
708288
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
719409
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3529333
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1251692
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2922286
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1966025
us-gaap Net Income Loss
NetIncomeLoss
-4614348
us-gaap Net Income Loss
NetIncomeLoss
-3997918
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23266587
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18828225
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23008941
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18435847
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Dilutive Securities
DilutiveSecurities
9982522
us-gaap Dilutive Securities
DilutiveSecurities
9754666
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2598
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
729681
CY2022Q2 idai Rental Expense
RentalExpense
110000
CY2021Q2 idai Rental Expense
RentalExpense
147000
idai Rental Expense
RentalExpense
255000
idai Rental Expense
RentalExpense
292000
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
267000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.59
CY2022Q2 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
44000
CY2021Q2 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
229000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
459646
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
657928
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
747432
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
830039
CY2022Q2 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
34000
CY2021Q2 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
0
idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
63000
idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
0
CY2022Q2 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2021Q4 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2020Q4 idai Loan Receivable Term
LoanReceivableTerm
P3Y
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
335000
CY2020Q4 idai Loans Receivable With Abated Interest Rate
LoansReceivableWithAbatedInterestRate
0.0025
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1408240
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.20
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P24M
CY2020Q4 idai Loans Receivable Kind In Services Per Month
LoansReceivableKindInServicesPerMonth
9000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P36M
CY2022Q2 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
74000
CY2021Q4 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
130000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
249415
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
316907
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
109295
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
51466
CY2022Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
59460
CY2022Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
118920
CY2022Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
88762
CY2022Q2 us-gaap Contractual Obligation
ContractualObligation
267142

Files In Submission

Name View Source Status
idai-20220630xex31d2.htm Edgar Link pending
idai-20220630xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
idai-20220630_pre.xml Edgar Link unprocessable
idai-20220630_lab.xml Edgar Link unprocessable
idai-20220630_def.xml Edgar Link unprocessable
idai-20220630_cal.xml Edgar Link unprocessable
0001410578-22-002705-index-headers.html Edgar Link pending
0001410578-22-002705-index.html Edgar Link pending
0001410578-22-002705.txt Edgar Link pending
0001410578-22-002705-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idai-20220630.xsd Edgar Link pending
idai-20220630x10q.htm Edgar Link pending
idai-20220630xex31d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
idai-20220630x10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending